However, ODZ1 which contributes to GBM invasiveness2, a key feature of this aggressive cancer, is likely to be activated by different transcriptional pathways in response to an array of cell migration stimuli in the microenvironment of GBM cells. The gene discussed is TENM1; the disease is cancer.